{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Famindr.com%2Fepisodes%2F44-preclinical-testing-part-2-alzheimers-disease-august-2020-_UBHDhVx","width":444,"version":"1.0","type":"rich","title":"44 - Preclinical Testing Part 2: Alzheimer's Disease August 2020","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9a8ef428-72db-47cb-a5cb-a6a258a13785/b59c6a2c-383e-4ad3-9225-96c2e11eb6c4/slide31.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/9a0fab18-2898-4d1c-959d-8db7017523e4\" height=\"200\" width=\"100%\" title=\"44 - Preclinical Testing Part 2: Alzheimer&apos;s Disease August 2020\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"You'll hear about some big topics in Alzheimer's disease research in this episode! Ellen covers all of the pre-clinical studies from August 2020 testing potential new treatments targeting neuroinflammation, oxidative stress, mitochondria, metabolism, and lipids. This is the second part of three pre-clinical testing episodes this month, check out episode #42 for part 1, and look out for part 3, coming soon!"}